Starting MS treatment early can stop or slow the progression ... those who were treated with a DMT within 6 months of their first episode of MS had a: 45% lower risk of developing moderate ...
The treatment you get for gout can depend on the frequency and ... allopurinol is the first-line medication for lowering uric acid levels. Febuxostat is another uric acid-lowering medication ...
He was first diagnosed with it in 2019. File image/Reuters Who doesn’t know Beyonce ... If a man is diagnosed with breast cancer, the treatment is the same as women, which includes surgery, ...
Some book lovers would say you had me at the first line. That moment of first meeting, that first glance to me, however, is—don’t judge me—often the book cover, or the book title. From there, I am led ...
“We wound up with the ball on our own one-foot line with the goal 99 and two ... just approved by the FDA have become the first ever treatments to slow the progression of Niemann-Pick Type ...
A need therefore exists for alternative treatment strategies. The first-in-human study included 14 participants aged 28 to 75 years, with body mass indices ranging from 24 to 40 kg/m². Each ...
The first of the capital's new Piccadilly line trains arrived in London on Monday 14 October, ahead of a programme of rigorous testing "It's an exciting moment for London as testing begins on the new ...
Rwanda has begun the world's first clinical trial for a treatment of the Ebola-like Marburg virus, which has killed more than a dozen people in the country, the World Health Organization said Tuesday.
Alectinib, also known as Alecensa, is recommended as an option for the treatment of stage 1B (tumours 4cm or larger) to 3A ALK-positive non-small-cell lung cancer (NSCLC) after surgery to completely ...
Professor Merriman hopes these findings will lead to improved treatment for gout sufferers. "We hope that, in time, better and more accessible treatments will become available with the new targets ...
Professor Merriman hopes these findings will lead to improved treatment for gout sufferers. "We hope that, in time, better and more accessible treatments will become available with the new targets ...